Get screened at 45
Most people should begin colorectal cancer screenings at age 45, according to the latest recommendations from the American Cancer Society. If you have a family history of colorectal cancer or other risk factors, you may need to be screened earlier than 45. Speak with your healthcare provider about developing a screening plan for you. They can recommend when and how you should be screened.
A colonoscopy is considered the gold standard in colorectal cancer screening. It allows doctor to identify and remove polyps (growths that can turn into cancer) in the same procedure.
While colonoscopy is the most effective screening exam for colorectal cancer, there are screening kits you can do from the comfort of your home.
Colonoscopy and at-home tests are not the only options. There are several other methods to screen for colorectal cancer, and each method has its own pros and cons.
How to prepare for your colonoscopy
Preparing for your colonoscopy can be a daunting experience. Good prep ensures your doctor will have a clear look at your colon, which leads to stronger results. Find out what to do each day before your colonoscopy.
Each year, about 150,000 Americans are diagnosed with colorectal cancer.
With early detection, colorectal cancer has a 90% survival rate.
About 33% of eligible adults are not getting screened.
Preventing colorectal cancer
While colorectal cancer screening is the single most important thing you can do to prevent colorectal cancer, you may be able to lower your risk with simple lifestyle changes such as exercising and eating well. Be proactive about your health.
“I was otherwise healthy and active. Because they found my cancer at age 45 when I was eligible to get my first screening, I was able to beat cancer.”
Take the colon cancer screening quiz
Getting checked for colon cancer can save your life. Take a short quiz to receive personalized screening options based on your individual risk factors.
Initiative aims to reduce stigma and educate about screening choices, as the Colorectal Cancer Alliance launches a health equity fund to decrease disparities.
On the horizon are blood tests that have shown the ability to detect a variety of cancers including colorectal and rare cancers. Though these tests are still in development and are not yet approved by the FDA, clinical trials have shown impressive results.
In February of 2022, John and Mary experienced the unimaginable. Their 36-year-old son, Jonathan, died of stage IV colon cancer. Though Jonathan had been dealing with ulcerative colitis from the time he was twelve, no one would have predicted this outcome twenty-four years later.